Latest - Radiology

 
 
  • Before Signing an Offer Letter: Read This You just received an offer letter, but should you sign it right away? How legally binding is it? Is it the same as a contract? Experts weigh in.
  • Communication Strategies in Breast Cancer (HER2+)   A breast cancer specialist and a patient with HER2+ breast cancer share thoughts on improving communication regarding diagnosis of metastatic cancer, treatment considerations, and survivorship.
  • Knee Surgery Surge Not Linked to Premature Intervention A rise in total knee arthroplasty doesn’t appear to be due to operations on healthier patients, according to a meta-analysis. Questions remain about the best time for patients to undergo the procedure.
  • Surveillance Imaging After Head, Neck Cancer Remission? With no apparent benefit for most, investigators say routine surveillance imaging in asymptomatic patients with head and neck cancer "should be discouraged."
  • Study Confirms Small Blood Cancer Risk From CT Scans The increased risk of hematological malignancies from CT radiation exposure in children and young adults should be viewed in the context of the substantial benefit these scans offer, experts say.
  • Infographic: Careers That Tempt Doctors to Leave Medicine Physicians who are thinking about leaving the practice of medicine reveal which nonclinical career options most interest them.
  • Optimal Timing of Postop Radiosurgery for Brain Metastases Adjuvant stereotactic radiosurgery for brain metastases delivered within 22 to 30 days is associated with lower rates of adverse effects and a low failure rate, new research suggests.
  • S2 Episode 6: Pediatric Asthma: When Is It an Emergency?   When is it time to send a child with an asthma exacerbation to the emergency department? Join Drs Michael Wechsler and Todd Florin as they discuss.
  • The Future of Medicine Is RNA   Short interfering RNA drugs could be the next big game changers in pharmacotherapeutics.
  • COVID-19 Antivirals Can Trigger Viral Rebound Though antivirals are critical for reducing severe COVID-19 symptoms, researchers suggested that the medication may not always be needed for milder cases.
  • Why I'm Sticking With the USPSTF on Lung Cancer Screening ACS recommends continuing lung cancer screening to age 80, regardless of how long ago patients quit smoking. Dr Kenny Lin explains why he's following the USPSTF's recommendations for now.
  • Meta-Analysis Backs Nodal Radiation in Early Breast Cancer Investigators say their meta-analysis of 16 trials spanning six decades highlights the benefits patients and oncologists can expect from regional lymph node radiation for early breast cancer.
  • Practice-Changing Data in Prostate Cancer From ESMO 2023   Survival benefits using radioligand therapy and analyses identifying novel ways to better target treatment are among the prostate cancer highlights from ESMO 2023 discussed by Dr Oliver Sartor.
  • Artificial Womb Brings Tough Choices, But Who Tests It?   The artificial womb that is being developed could potentially save very premature infants, but testing it raises many issues.
  • AI Is Here. Is Your Practice Ready?   In this live panel, Dr Eric Topol, Dr Arjun Manrai, and Dr Ted A. James give their perspectives on AI's capabilities in diagnosis, treatment, precision medicine, and more.
  • FTC Considers Proposals on Mergers and Noncompete Clauses AMA and ACEP support proposed changes that would affect workforce hiring and working conditions for physicians.
  • Can't-Miss Highlights From ACG 2023: Part 1   Dr David Johnson comments on new data around eosinophilic esophagitis, behavioral therapies for IBS, and two new drugs on the fast track for approval.
  • Classification Identifies Four Stages of Heart Attack In a consensus statement, the Canadian Cardiovascular Society defines four stages of acute atherothrombotic myocardial infarction based on tissue injury severity.
  • SITC 2023 T-Cell Cancers: CAR T Therapy to the Rescue? Scientists are seeing positive early results from treating relapsed/refractory T-cell blood cancers with un–gene-edited chimeric antigen receptor (CAR) T-cell therapy.
  • Catching a Killer   Marcy Duncan hadn't fully healed from her surgery for stage I breast cancer. She expected to discuss radiation and other next treatment steps. But her doctor raised a more serious concern.